Results 141 to 150 of about 16,628 (221)

Medication Purchases Are Associated With the Number of Dental Treatments. [PDF]

Clin Exp Dent Res
Frankenhaeuser F, Källmén H, Meurman J, Korpi E, Söder B.   +4 more
europepmc   +1 more source

Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022. [PDF]

Arthritis Rheumatol
Yalamanchili P, Lee LY, Bushnell G, Mannion ML, Dave CV, Horton DB.   +5 more
europepmc   +1 more source

Osteoclast development from peripheral blood monocytes is reduced in patients with radiographic axial spondyloarthritis on biological therapy. [PDF]

Arthritis Res Ther
Engdahl C, Erlandsson MC, Hallström M, Deminger A, Forsblad-d'Elia H.   +4 more
europepmc   +1 more source

Trends in Psoriatic Arthritis Management From 1993 to 2019: Rise of Biologics and Decline of Oral Small Molecules. [PDF]

J Psoriasis Psoriatic Arthritis
Woodie BR, Balachandar S, Fleischer AB.
europepmc   +1 more source

Effects of Biological and Non Biological Agents (Disease Modifying Antirheumatic Drugs) on Bone Mineral Density in a Sample of Rheumatoid Arthritis Patients

, 2018
Mohammed H. Alosami, Omar Farooq Al-Azzawi, Faiq I. Gorial, Israa Mohammed Redia   +3 more
openalex   +2 more sources

Physical and mental disability is evident 8 years after diagnosis in early rheumatoid arthritis despite contemporary medication and non-pharmacological interventions. [PDF]

Clin Rheumatol
Thyberg I, Husberg M, Kastbom A.
europepmc   +1 more source

Immunomodulating effects of My 6596, β-(p-chlorophenyl)-∝-(p-fluorobenzoyl thiomethyl)-γ-butyrolactone, a novel antirheumatic agent

, 1986
Shuichiro Kadowaki, Kumiko Sugasawa, Susumu Mizogami   +2 more
openalex   +1 more source

Abatacept, Golimumab, and Sarilumab as Selected Bio-Originator Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action in Their Current Use in Treatment. [PDF]

J Clin Med
Kawczak P, Feszak IJ, Bączek T.
europepmc   +1 more source

Detection of substantial numbers of latent tuberculosis and positive hepatitis B serology results in rheumatology patients preparing to receive intensified immunosuppressive therapy in a low-prevalence country: why screening still matters. [PDF]

Clin Rheumatol
Feuchtenberger M, Kovacs MS, Nigg A, Schäfer A.   +3 more
europepmc   +1 more source

Antirheumatic Agents. III. Novel Methotrexate Derivatives Bearing an Indoline Ring and a Modified Ornithine or Glutamic Acid.

, 1997
Hirotaka Matsuoka, Naoki Kato, Naoto Ohi, Ken–ichi Miyamoto, Masahiko Mihara, Y. Takeda   +5 more
openalex   +2 more sources